Sentence examples for may demonstrate improvements from inspiring English sources

For example, improved BRIEF subscale score for emotional control may demonstrate improvements in the child's ability to better manage emotional responses and, therefore, core EF behaviors such as emotional regulation and frustration modulation [ 18, 20, 21].

It is possible that an analysis using post-2006 data may demonstrate improvements though these data were not available at the time of the current study.

Possessing longer half-lives than vancomycin, these newer candidates may demonstrate improvements over vancomycin due to less frequent dosing and activity against vancomycin-resistant bacteria.

Further studies may demonstrate improved clinical outcome for video calls, given such improvements.

Clearly, the results obtained with the seven analogues included in the present study also suggest that additional carbamoylated sugars may demonstrate further improvements in the efficiency of tumor cell targeting/uptake.

All patients had normal ejection fractions at baseline, however, which may partly explain the lack of a consistent beneficial effect on myocardial physiology with ramipril (it may have been difficult to demonstrate improvements in normal function), though the study may also be under-powered to show changes in these parameters.

It is clear in the literature that interventions that aim to improve self-efficacy in patients may demonstrate potential improvement in health outcomes.

25 Our study may have been underpowered to demonstrate improvements in CIMT, but it is equally possible that anti-TNF therapy prevented increases in CIMT that would have occurred without treatment.

As a consequence of this work, certain significant modifications to the clinical examination can be made and subsequent studies may demonstrate an improvement on what we achieved here.

It is in these patients where TA has emerged as a viable treatment option and may demonstrate significant improvement in survival and outcome.

Passed in July 2012, FDASIA defines eligibility for the pathway as a product that is "intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition and for which preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints".